CH638186A5 - Neue pyridinyl-aminoalkylaether. - Google Patents

Neue pyridinyl-aminoalkylaether. Download PDF

Info

Publication number
CH638186A5
CH638186A5 CH278478A CH278478A CH638186A5 CH 638186 A5 CH638186 A5 CH 638186A5 CH 278478 A CH278478 A CH 278478A CH 278478 A CH278478 A CH 278478A CH 638186 A5 CH638186 A5 CH 638186A5
Authority
CH
Switzerland
Prior art keywords
alkyl
carbon atoms
benzyl
hydrogen
methyl
Prior art date
Application number
CH278478A
Other languages
German (de)
English (en)
Inventor
Gerda Von Dr Philipsborn
Walter Dr Boell
Dieter Dr Lenke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of CH638186A5 publication Critical patent/CH638186A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0018Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C2204/00Features not otherwise provided for
    • A61C2204/002Features not otherwise provided for using batteries

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH278478A 1977-03-17 1978-03-14 Neue pyridinyl-aminoalkylaether. CH638186A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772711655 DE2711655A1 (de) 1977-03-17 1977-03-17 Pyridinyl-aminoalkylaether

Publications (1)

Publication Number Publication Date
CH638186A5 true CH638186A5 (de) 1983-09-15

Family

ID=6003884

Family Applications (1)

Application Number Title Priority Date Filing Date
CH278478A CH638186A5 (de) 1977-03-17 1978-03-14 Neue pyridinyl-aminoalkylaether.

Country Status (27)

Country Link
US (1) US4206117A (US20020128544A1-20020912-P00008.png)
JP (1) JPS53116382A (US20020128544A1-20020912-P00008.png)
AT (2) AT364360B (US20020128544A1-20020912-P00008.png)
AU (1) AU525566B2 (US20020128544A1-20020912-P00008.png)
BE (1) BE864917A (US20020128544A1-20020912-P00008.png)
CA (1) CA1108148A (US20020128544A1-20020912-P00008.png)
CH (1) CH638186A5 (US20020128544A1-20020912-P00008.png)
CS (2) CS202012B2 (US20020128544A1-20020912-P00008.png)
DD (1) DD134090A5 (US20020128544A1-20020912-P00008.png)
DE (1) DE2711655A1 (US20020128544A1-20020912-P00008.png)
DK (1) DK118578A (US20020128544A1-20020912-P00008.png)
ES (1) ES467931A1 (US20020128544A1-20020912-P00008.png)
FI (1) FI74962C (US20020128544A1-20020912-P00008.png)
FR (1) FR2383930A1 (US20020128544A1-20020912-P00008.png)
GB (1) GB1599061A (US20020128544A1-20020912-P00008.png)
GR (1) GR64096B (US20020128544A1-20020912-P00008.png)
HU (1) HU177287B (US20020128544A1-20020912-P00008.png)
IE (1) IE46484B1 (US20020128544A1-20020912-P00008.png)
IL (1) IL54265A0 (US20020128544A1-20020912-P00008.png)
IT (1) IT1093796B (US20020128544A1-20020912-P00008.png)
LU (1) LU79235A1 (US20020128544A1-20020912-P00008.png)
NL (1) NL189563C (US20020128544A1-20020912-P00008.png)
NO (1) NO150605C (US20020128544A1-20020912-P00008.png)
SE (1) SE446185B (US20020128544A1-20020912-P00008.png)
SU (2) SU799658A3 (US20020128544A1-20020912-P00008.png)
YU (2) YU63678A (US20020128544A1-20020912-P00008.png)
ZA (1) ZA781552B (US20020128544A1-20020912-P00008.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474781A (en) * 1979-04-02 1984-10-02 Merck & Co., Inc. Treating hypertension with aminoalkoxypyridines
DE3008522A1 (de) * 1980-03-06 1981-09-17 Basf Ag, 6700 Ludwigshafen 4-(alpha)-cycloamino-arylmethyl-6-methyl-1,3-dihydro-furo (3,4-c) -pyridin-7-ole, ihre herstellung und verwendung
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
JPS588066A (ja) * 1981-07-03 1983-01-18 Otsuka Pharmaceut Co Ltd 光学活性〔s〕−(−)−カルボスチリル誘導体の製造法
DE3373466D1 (de) * 1982-06-10 1987-10-15 Beecham Wuelfing Gmbh & Co Kg Amine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
GB9012926D0 (en) * 1990-06-09 1990-08-01 Scras Pyrrolo-pyridine derivatives
CA2396738C (en) * 1990-11-30 2006-08-29 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US20010034357A1 (en) * 2000-02-02 2001-10-25 Nan-Horng Lin Substituted pyridine compounds useful for controlling chemical synaptic transmission
WO2004092130A2 (en) * 2003-04-07 2004-10-28 Kalypsys, Inc. N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
CN102177153B (zh) * 2008-10-10 2016-09-21 Vm生物医药公司 治疗酒精使用障碍,疼痛和其他疾病的药物组合与方法
KR101698153B1 (ko) * 2010-04-26 2017-01-23 광주과학기술원 P2x1 및 p2x3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
US1881236A (en) * 1929-08-10 1932-10-04 Soc Of Chemical Ind Basic ethers of the pyridine series
US3535328A (en) * 1967-09-01 1970-10-20 Exxon Research Engineering Co Certain substituted aminothioethoxy pyridines
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR208397A1 (es) * 1973-02-20 1976-12-27 Ciba Geigy Ag Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
US4073909A (en) * 1973-10-08 1978-02-14 Sandoz Ltd. Isoquinoline compounds
CH592625A5 (US20020128544A1-20020912-P00008.png) 1974-05-14 1977-10-31 Ciba Geigy Ag
CH614711A5 (US20020128544A1-20020912-P00008.png) * 1975-04-08 1979-12-14 Sandoz Ag
GB1504424A (en) * 1975-08-09 1978-03-22 Beecham Group Ltd Isoquinoline-derived aminoethers
GB1485919A (en) 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines

Also Published As

Publication number Publication date
AT364360B (de) 1981-10-12
GB1599061A (en) 1981-09-30
NL7802719A (nl) 1978-09-19
ATA187878A (de) 1981-03-15
DK118578A (da) 1978-09-18
YU63678A (en) 1983-01-21
ES467931A1 (es) 1979-07-01
FI780842A (fi) 1978-09-18
SE7802927L (sv) 1978-09-18
FI74962C (fi) 1988-04-11
GR64096B (en) 1980-01-22
FI74962B (fi) 1987-12-31
YU41016B (en) 1986-10-31
CS202012B2 (en) 1980-12-31
IT7821099A0 (it) 1978-03-10
DD134090A5 (de) 1979-02-07
SU850002A3 (ru) 1981-07-23
NO150605C (no) 1984-11-14
IL54265A0 (en) 1978-06-15
NL189563C (nl) 1993-05-17
NO150605B (no) 1984-08-06
AT364361B (de) 1981-10-12
AU3419578A (en) 1979-09-20
FR2383930A1 (fr) 1978-10-13
DE2711655A1 (de) 1978-09-21
NL189563B (nl) 1992-12-16
JPS6123790B2 (US20020128544A1-20020912-P00008.png) 1986-06-07
BE864917A (fr) 1978-09-15
ATA84080A (de) 1981-03-15
IE780503L (en) 1978-09-17
HU177287B (en) 1981-09-28
CA1108148A (en) 1981-09-01
SE446185B (sv) 1986-08-18
LU79235A1 (de) 1978-06-28
YU225282A (en) 1983-02-28
JPS53116382A (en) 1978-10-11
NO780931L (no) 1978-09-19
AU525566B2 (en) 1982-11-11
FR2383930B1 (US20020128544A1-20020912-P00008.png) 1982-10-22
ZA781552B (en) 1979-04-25
DE2711655C2 (US20020128544A1-20020912-P00008.png) 1987-07-16
US4206117A (en) 1980-06-03
IT1093796B (it) 1985-07-26
CS202011B2 (en) 1980-12-31
IE46484B1 (en) 1983-06-29
SU799658A3 (ru) 1981-01-23

Similar Documents

Publication Publication Date Title
CH638186A5 (de) Neue pyridinyl-aminoalkylaether.
EP0204269B1 (de) Pyridin-Derivate, ihre Herstellung und Verwendung
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
EP0101574B1 (de) 2-Substituierte 1-Aminoalkyl-1,2,3,4-tetrahydro-beta-carboline, ihre Herstellung und Verwendung als Arzneimittel
EP0163260B1 (de) Neue substituierte Pyrrolidinone, Verfahren zu ihrer Herstellung und Arzneimittel
CH643809A5 (de) Aminoalkohol-derivate.
US3381012A (en) Primary, secondary, and tertiary-(1-piperidyl)-lower-alkylamines
EP0065295A1 (de) Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
DE3900028A1 (de) Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
EP0064685A1 (de) Dibenzo(de,g)chinolin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0027928B1 (de) Piperidinderivate von 4,5-Dialkyl-3-hydroxy-pyrrol-2-carbonsäureestern, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE3301198A1 (de) N-arylalkylamin-3-propoxypyridin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
EP0030688B1 (de) Piperidinderivate von 3-Hydroxy-thiophen-2-carbonsäureestern, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
US3687936A (en) 11-AMINOALIPHATIC-5:10-METHANODIBENZO {8 a:d{9 {0 {8 1:4{9 {0 CYCLOHEPTADIENES AND THE SALTS THEREOF
DE2760038C2 (US20020128544A1-20020912-P00008.png)
DD149664A5 (de) Verfahren zur herstellung von 1,1'-biphenyl-2-yl-alkylamin-derivaten
EP0462150B1 (de) Neue aryloxy-alkylamine, deren herstellung und diese enthaltende arzneimittel
DE3519693C1 (US20020128544A1-20020912-P00008.png)
EP0027977A1 (de) Aminoderivate des 2-Methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
EP0003298A2 (de) 4-Hydroxy-2-benzimidazolin-thion-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
CS239947B2 (en) Processing of new benzazepin derivatives
CH637939A5 (de) Pyridin-3-ole.
AT330163B (de) Verfahren zur herstellung neuer derivate des 2-aminoindans
AT336617B (de) Verfahren zur herstellung von neuen heterocyclischen verbindungen

Legal Events

Date Code Title Description
PL Patent ceased